Literature DB >> 12690651

Paraneoplastic neurologic syndromes.

Luis Bataller1, Josep Dalmau.   

Abstract

Cancer can affect the nervous system through many metastatic and nonmetastatic mechanisms, including side effects of cancer treatment, infections, coagulopathy, and metabolic or nutritional deficits. Paraneoplastic neurologic disorders (PND) are an extensive group of syndromes that cannot be explained by any of these complications and may affect any part of the nervous system. PND often develop before the presence of a cancer is known and their recognition may lead to the tumor diagnosis.

Entities:  

Mesh:

Year:  2003        PMID: 12690651     DOI: 10.1016/s0733-8619(02)00037-3

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  11 in total

Review 1.  Spinal cord compression in cancer patients: review of diagnosis and treatment.

Authors:  Marta Penas-Prado; Monica E Loghin
Journal:  Curr Oncol Rep       Date:  2008-01       Impact factor: 5.075

2.  [Paraneoplastic cerebellar degeneration (PCD) - an interdisciplinary challenge in neurology, oncology and palliative care].

Authors:  Sabine Burger; Stefan Lorenzl
Journal:  Wien Med Wochenschr       Date:  2018-02-06

3.  Paraneoplastic Opsoclonus-Myoclonus Syndrome: initial presentation of non-Hodgkins lymphoma.

Authors:  Ashwani Kumar; Walter A Lajara-Nanson; Robert W Neilson
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

Review 4.  Advances in Autoimmune Epilepsy Associated with Antibodies, Their Potential Pathogenic Molecular Mechanisms, and Current Recommended Immunotherapies.

Authors:  Zhiwei Fang; Yunqi Yang; Xuan Chen; Weiwang Zhang; Yangmei Xie; Yinghui Chen; Zhenguo Liu; Weien Yuan
Journal:  Front Immunol       Date:  2017-04-25       Impact factor: 7.561

5.  Paraneoplastic limbic encephalitis in a patient with extensive disease small-cell lung cancer.

Authors:  Sebastian Ochenduszko; Bartosz Wilk; Joanna Dabrowska; Izabela Herman-Sucharska; Anna Dubis; Miroslawa Puskulluoglu
Journal:  Mol Clin Oncol       Date:  2017-02-10

Review 6.  Clinical applications of a peptide-based vaccine for glioblastoma.

Authors:  Charles W Kanaly; Dale Ding; Amy B Heimberger; John H Sampson
Journal:  Neurosurg Clin N Am       Date:  2010-01       Impact factor: 2.509

7.  Anti-Ri antibodies associated with short-term memory deficits and a mature cystic teratoma of the ovary.

Authors:  Oluwole Fadare; Hassan J Hart
Journal:  Int Semin Surg Oncol       Date:  2004-11-10

8.  Paraneoplastic cerebellar degeneration associated with ovarian cancer.

Authors:  Alessia Erika Russo; Simona Scalone; Giulia Costanza Leonardi; Aurora Scalisi; Giorgio Giorda; Roberto Sorio
Journal:  Oncol Lett       Date:  2012-11-07       Impact factor: 2.967

9.  Pyridoxal phosphatase is a novel cancer autoantigen in the central nervous system.

Authors:  A S Bøe; G Bredholt; P M Knappskog; A Storstein; C A Vedeler; E S Husebye
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640

Review 10.  Are onconeural antibodies a clinical phenomenology in paraneoplastic limbic encephalitis?

Authors:  Hongliang Zhang; Chunkui Zhou; Limin Wu; Fengming Ni; Jie Zhu; Tao Jin
Journal:  Mediators Inflamm       Date:  2013-07-25       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.